Individualized vaccines for cancer | Patent Number 11248264

US 11248264 B2
Application Number16920286
Publication NumberUS 20210164034 A1
Pendency1 year, 7 months, 18 days
Filled DateJul 2, 2020
Priority DateMay 23, 2012
Publication DateJun 3, 2021
Expiration DateMay 22, 2032
Inventor/ApplicantsBernhard Renard
John Christopher Castle
Michael Koslowski
Jan Diekmann
Johannes Hendrikus De Graaf
Ugur Sahin
Sebastian Kreiter
Cedrik Britten
Martin Lower
Mustafa Diken
Tana Omokoko
ExaminesMONTANARI, DAVID A
Art Unit1632
Technology Center1600
Assignments
Biontech Ag
Current
Biontech Ag
Original
Tron Translationale Onkologie An Der Universitatsmedizin Der Johannes Gutenberguniversitat Mainz Gemeinnutzige Gmbh
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.